切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2021, Vol. 15 ›› Issue (02) : 117 -123. doi: 10.3877/cma.j.issn.1674-1358.2021.02.008

所属专题: 经典病例 文献

论著

25例儿童社区获得性铜绿假单胞菌血流感染的临床特点及预后影响因素
郭张妍1, 王娟1,(), 楚建平1   
  1. 1. 710003 西安市,西安市儿童医院PICU
  • 收稿日期:2020-04-19 出版日期:2021-04-15
  • 通信作者: 王娟

Clinical characteristics and prognostic factors of 25 cases with community-acquired pseudomonas aeruginosa bloodstream infection

Zhangyan Guo1, Juan Wang1,(), Jianping Chu1   

  1. 1. Pediatric Intensive Care Unit, Xi’an Children’s Hospital, Xi’an 710003, China
  • Received:2020-04-19 Published:2021-04-15
  • Corresponding author: Juan Wang
引用本文:

郭张妍, 王娟, 楚建平. 25例儿童社区获得性铜绿假单胞菌血流感染的临床特点及预后影响因素[J/OL]. 中华实验和临床感染病杂志(电子版), 2021, 15(02): 117-123.

Zhangyan Guo, Juan Wang, Jianping Chu. Clinical characteristics and prognostic factors of 25 cases with community-acquired pseudomonas aeruginosa bloodstream infection[J/OL]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2021, 15(02): 117-123.

目的

探讨儿童社区获得性铜绿假单胞菌血流感染的临床特点及预后影响因素,为其诊治及预后评估提供依据。

方法

对2013年1月至2018年12月西安市儿童医院儿童重症监护病房诊断为社区获得性铜绿假单胞菌血流感染的25例患儿的资料进行回顾性分析,对其临床特点、实验室指标、药敏试验结果和疗效进行分析,并采用单因素和多因素Cox回归分析影响生存预后的相关因素。

结果

诊断为社区获得性铜绿假单胞菌血流感染患儿共25例,其中婴幼儿21例(84%)。25例患儿中发热23例(92%),精神反应差23例(92%),白细胞减少18例(72%),白细胞升高4例(16%),25例(100%)患儿C-反应蛋白(CRP)和降钙素原(PCT)均升高,分别为(76.6 ± 34.3)mg/L和[35.4(7.67,43.25)]ng/ml。25例患儿中存活6例,死亡19例,病死率为76%。白细胞(Z =-2.132、P = 0.033)、血乳酸(t = 4.480、P < 0.001)、入院前不恰当使用抗菌药物(P < 0.001)、机械通气(P = 0.031)、感染性休克(P < 0.001)对儿童社区获得性铜绿假单胞菌血流感染预后有显著影响,差异均有统计学意义。多因素Cox回归分析显示入院前不恰当使用抗菌药物(OR = 0.091、P = 0.027)和感染性休克(OR = 3.898、P = 0.038)是儿童社区获得性铜绿假单胞菌血流感染预后的独立危险因素。

结论

儿童社区获得性铜绿假单胞菌血流感染表现为发热、精神差、白细胞升高或减少、CRP和PCT水平明显升高,病死率高。入院前不恰当使用抗菌药物和合并感染性休克均为患儿死亡的高危因素。合理使用抗菌药物和恰当的经验治疗将有利于降低社区获得性铜绿假单胞菌血流感染的病死率。

Objective

To investigate the clinical characteristics and risk factors of prognosis in children with community-acquired Pseudomonas aeruginosa bloodstream infection and to provide basis for clinical diagnosis, treatment and prognosis evaluation.

Methods

The clinical data of 25 cases diagnosed as community-acquired Pseudomonas aeruginosa bloodstream infection in Pediatric Intensive Care Unit, Xi’an Children’s Hospital, from January 2013 to December 2018 were analyzed, retrospectively. The clinical characteristics, laboratory tests, drug sensitivity results and treatment were analyzed, respectively. Univariate and multivariate Cox regression were used to analyze the related factors affecting survival prognosis.

Results

There were 25 cases with community-acquired Pseudomonas aeruginosa bloodstream infection, 21 cases were infants and toddlers. Among the 25 cases, 23 (92%) cases had fever, 23 (92%) cases had poor mental state, 18 (72%) cases had leukopenia, 4 (16%) cases had leukocytosis, C-reactive protein (CRP) and procalcitonin (PCT) increased among 25 cases (100%), which were (76.6 ± 34.3) mg/L and [35.4 (7.67, 43.25)] ng/ml, respectively.Total of 19 cases survived and 6 cases died, with the fatality rate as 76%. White blood cell (Z =-2.132, P = 0.033), blood lactic acid (t = 4.480, P < 0.001), inappropriate pre-hospital antibiotics (P < 0.001), mechanical ventilation (P = 0.031), septic shock (P < 0.001) significantly affected the prognosis of community-acquired Pseudomonas aeruginosa bloodstream infection in children, with significant differences. Multivariate Cox regression analysis showed that inappropriate pre-hospital antibiotics (OR = 0.091, P = 0.027) and septic shock (OR = 3.898, P = 0.038) were risk factors affecting the prognosis of pseudomonas aeruginosa bloodstream infection.

Conclusions

Community-acquired Pseudomonas aeruginosa infection of children presents as fever, poor mental state, increased or decreased white blood cells, significantly increased CRP and PCT, with high fatality rate. Inappropriate pre-hospital antibiotics and septic shock were independent risk factors for prognosis of community-acquired pseudomonas aeruginosa bloodstream infection in children. Rational use of antibiotics and more approriate antimicrobial therapy might improve the outcomes of children with community-acquired Pseudomonas aeruginosa bloodstream infection.

表1 25例铜绿假单胞菌血流感染患儿的一般资料和实验室指标
表2 25株铜绿假单胞菌对抗菌药物的药敏试验结果[株(%)]
图1 典型患儿病程不同时期的皮疹变化
表3 社区获得性铜绿假单胞菌血流感染儿童生存相关危险因素
表4 影响儿童铜绿假单胞菌血流感染预后的多因素Cox回归分析
[1]
Rosanova MT, Mussini MS, Arias AP, et al. Epidemiological features and risk factors for mortality in Pseudomonas aeruginosa bacteremia in children[J]. Arch Argent Pediatr,2019,117(2):128-131.
[2]
董方, 王艳, 刘锡青, 等. 2009-2015年北京儿童医院临床分离细菌的分布及耐药性监测[J]. 中国感染与化疗杂志,2017,17(1):61-70.
[3]
Pfaller MA, Flamm RK, Duncan LR, et al. Antimicrobial activity of tigecycline and cefopperazone/sulbactam tested against 18 386 Gram-negative arganisms from Europe and the Asia Pacific region (2013-3014)[J]. Diagn Microbiol Infect Dis,2017,88(2)177-183.
[4]
Miyoshi-akiyamat T, TAada T, Ohmagari N, et al. Emer-gence and spread of Epidemic multidrug-resistant Pseudomonas earuginosa[J]. Genome Biol Evol,2017,9(12):3238-3245.
[5]
Thong KL, Lai MY, Teh C SJ, et al. Simultaneous detection of methicillin-resistant Staphylococcus aureus, Aeinetobaeter baumannii, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa by multiplex PCR[J]. Trop Biomed,2011,28(1):21-31.
[6]
Parkins MD, Gregson DB, Pitout JD, et al. Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection[J]. Infection,2010,38(1):25-32.
[7]
Soothill J. Use of bacteriophages in the treatment of Pseudomonas aeruginosa infections[J]. Expert Rev Anti Infect Ther,2013,11(9):909-915.
[8]
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twenty-Seventh Informational Supplement,2017:M100S. 27th Edition.
[9]
任伟, 龙晓玲, 周涛, 等. 儿童铜绿假单胞菌脓毒症14例临床分析[J]. 临床儿科杂志,2016,34(9):674-676.
[10]
Alaga L, Mediavilla JD, Cobo F. A clinical index predicting mortality with Pseudomonas aeruginosa bacteraemia[J]. J Med Microbiol,2002,51(7):615-619.
[11]
王真, 刘青, 蒋慧杨, 等. 儿童急性淋巴细胞白血病中性粒细胞缺乏伴发热单中心血流感染病原菌分析[J]. 循证儿科杂志,2019,14(3):186-190.
[12]
Dantas RC, Ferreira ML, Gontijo-Filho PP, et al. Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome[J]. J Med Microbiol,2014,63(12): 1679-1687.
[13]
Hu Y, Li L, Li W, et al. Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: a meta-analysis of retrospective and prospective studies[J]. Int J Antimicrob Agents,2013,42(6):492-496.
[14]
Kim YJ, Jun YH, Kim YR, et al. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy[J]. BMC Infect Dis,2014,14:161.
[15]
Gargouri L, Maaloul I, Kamoun T, et al. Ecthyma gangrenosum: A manifestation of community-acquired Pseudomonas aeruginosa septicemia in three infants[J]. Arch Pediatr,2015,22(6):616-620.
[16]
Yan W, Li W, Mu C, et al. Ecthyma gangrenosum and multiple nodules: cutaneous manifestations of Pseudomonas aeruginosa sepsis in a previously healthy infant[J]. Pediatr Dermatol,2011,28(2):204- 205.
[17]
高娅, 李娇, 杜鑫珂, 等. 54例儿童铜绿假单胞菌血流感染临床特点及耐药分析[J]. 临床儿科杂志,2019,37(2):118-122.
[18]
周益平, 张育才. 铜绿假单胞菌脓毒症的临床特征与救治策略[J]. 中国小儿急救医学,2011,18(4):375-377.
[19]
Viola L, Langer A, Pulitano S, et al. Serious Pseudomonas aeruginosa infection in health children: Case report and review of the literature[J]. Pediatr Int,2006,48(3):330-333.
[20]
何时军, 金益梅, 黄爱蓉, 等. 儿童社区获得性铜绿假单胞菌致感染性休克九例分析[J]. 中华儿科杂志,2008,46(5):333-338.
[21]
Lodise TP Jr, Patel N, Kwa A, et al. Predietors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections:impact of delayed appropriate antibiotic seleetion[J]. Antimicrob Agents Chemother,2007,51(10):3510-3515.
[22]
Kang CI, Kim SH, Kim HB, et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome[J]. Clin Infect Dis,2003,37(6):745-751.
[23]
Kim HS, Park BK, Kim SK, et al. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study[J]. BMC Infect Dis,2017,17(1):500.
[24]
Koichi Kitagawa K, Shigemura K, Yamamichi F, et al. Bacteremia complicating urinary tract infection by Pseudomonas aeruginosa: Mortality risk factors[J]. Int J Urol,2019,26(3):358-362.
[25]
陈愉生, 吴春兰, 李鸿茹, 等. 铜绿假单胞菌血流感染56例临床分析[J]. 中国感染与化疗杂志,2016,16(5):529-535.
[26]
Thirumalmuhu K, Devarajan B, Prajna L, et al. Mechanisms of fluoroquinolone and aminoglycoside resistance in keratitisassociated Pseudomonas aeruginosa[J]. Microb Drug Resist,2019,25(6):813-823.
[27]
Barbier F, Andremont A, Wolff M, et al. Hospital-acquired pneumonia and ventilator associated pneumonia: recent advances in epidemiology and management[J]. Curr Opin Pulm Med,2013,19(3):216-228.
[28]
Saxena P, Joshi Y, Rawat K, et al. Biofilms: architecture, resistance, quorum densing and control mechanisms[J]. Indian J Microbiol,2019,59(1):3-12.
[29]
Correia S, Poeta P, Hebraud M, et al. Mechanisms of quinolone action and resistance:where do we stand?[J]. J Med Microbiol,2017,66(5): 551-559.
[30]
Hammer KL, Justo JA, Bookstaver PB, et al. Differential effect of prior β-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa[J]. Diagn Microbiol Infect Dis,2017,87(1):87-91.
[31]
Paulsson M, Granrot A, Ahl J, et al. Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study[J]. Eur J Clin Microbiol Infect Dis,2017,36(7):1187-1196.
[1] 陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 959-965.
[2] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[3] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[4] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[5] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[6] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[7] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[8] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[9] 陈宗杰, 胡添松. 肝外伤破裂患者治疗后胆漏发生影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 836-840.
[10] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[11] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[12] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[13] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[14] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[15] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
阅读次数
全文


摘要